2021
DOI: 10.1177/20458940211050469
|View full text |Cite
|
Sign up to set email alerts
|

Pulmonary arterial hypertension in pediatric patients undergoing high‐dose carboplatin/thiotepa and stem cell transplant

Abstract: Pulmonary arterial hypertension (PAH) in pediatric patients is associated with significant morbidity and mortality. Few studies exist to evaluate the incidence of PAH in pediatric oncology patients treated with carboplatin and thiotepa followed by hematopoietic stem cell transplant (HSCT). We describe two pediatric patients who developed PAH following high dose chemotherapy with carboplatin and thiotepa followed by autologous HSCT. These cases highlight the need for a surveillance protocol and reinforce the ne… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 9 publications
(30 reference statements)
0
0
0
Order By: Relevance